William D Tap

William D Tap

UNVERIFIED PROFILE

Are you William D Tap?   Register this Author

Register author
William D Tap

William D Tap

Publications by authors named "William D Tap"

Are you William D Tap?   Register this Author

96Publications

2889Reads

21Profile Views

Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.

Mod Pathol 2019 Sep 19. Epub 2019 Sep 19.

Department of Pathology, Memorial Sloan Kettering Cancer Center, Manhattan, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0368-8DOI Listing
September 2019

Incidence and Management of Olaratumab Infusion-Related Reactions.

J Oncol Pract 2019 Jul 3:JOP1800761. Epub 2019 Jul 3.

Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00761DOI Listing
July 2019

Multidisciplinary care in tenosynovial giant cell tumours.

Authors:
William D Tap

Lancet Oncol 2019 Jun 24;20(6):755-756. Epub 2019 Apr 24.

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, 10065 NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30173-1DOI Listing
June 2019

Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.

J Geriatr Oncol 2019 May 22. Epub 2019 May 22.

Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.05.008DOI Listing
May 2019

Prognostication and Communication in Oncology.

J Oncol Pract 2019 Apr 25;15(4):208-215. Epub 2019 Mar 25.

7 University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00647
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00647DOI Listing
April 2019

Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma.

Cancer Chemother Pharmacol 2019 01 8;83(1):191-199. Epub 2018 Nov 8.

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, 1275 York Ave, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-018-3723-4
Publisher Site
http://dx.doi.org/10.1007/s00280-018-3723-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373189PMC
January 2019

Establishing a Mutually Respectful Environment in the Workplace: A Toolbox for Performance Excellence.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:e219-e226. Epub 2019 May 17.

5 Department of Radiation Medicine, Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_249529DOI Listing
January 2019

Sorafenib for Advanced and Refractory Desmoid Tumors.

N Engl J Med 2018 12;379(25):2417-2428

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center (M.M.G., W.D.T., N.H., N.P.A., R.A.L., Y.M., R.Y.) and Columbia University Vagellos College of Physicians and Surgeons and New York Presbyterian Hospital (L.H.S., G.K.S.), New York, and Northwell Cancer Institute and Cold Spring Harbor Laboratory, Lake Success (R.G.M.) - all in New York; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (M.R.M.); Washington University School of Medicine, St. Louis (B.A.V.T.); M.D. Anderson Cancer Center, University of Texas, Houston (V.R.); Mayo Clinic in Florida, Jacksonville (S.A.); Yale University, New Haven, CT (H.A.D.); University Health Network Princess Margaret Cancer Centre, Toronto (A.A.G.); University of Iowa-Holden Comprehensive Cancer Center, Iowa City (M.M.M.); University of Alabama at Birmingham Cancer Center, Birmingham (R.M.C.); Fox Chase Cancer Center, Philadelphia (S.M.); Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC (M.J.P.); Duke Cancer Institute, Duke University Medical Center, Durham (R.F.R.), and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill (E.B.) - both in North Carolina; Dayton National Cancer Institute Community Oncology Research Program, Dayton, OH (T.S.); National Cancer Institute, Bethesda, MD (J.J.W.); and the Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ (A.C.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1805052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447029PMC
December 2018

TOMAS: revisiting PARP inhibitor combination therapy.

Lancet Oncol 2018 10 11;19(10):1269-1270. Epub 2018 Sep 11.

Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30494-7DOI Listing
October 2018

PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence.

Oncogene 2018 09 23;37(37):5066-5078. Epub 2018 May 23.

Departments of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-018-0332-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137027PMC
September 2018

Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience.

Urology 2018 Sep 21;119:55-61. Epub 2018 Jun 21.

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2018.06.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666395PMC
September 2018

CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought.

Cancer Cell 2018 07 3;34(1):9-20. Epub 2018 May 3.

The Louis V. Gerstner Graduate School of Biomedical Sciences and the Sloan Kettering Institute Program in Molecular Biology, Memorial Sloan Kettering Cancer Center, RRL917C, Box 207, 1275 York Avenue, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.03.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039233PMC
July 2018

Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas.

Oncogenesis 2018 Jun 19;7(6):47. Epub 2018 Jun 19.

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41389-018-0059-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006341PMC
June 2018

Trametinib in Histiocytic Sarcoma with an Activating MAP2K1 (MEK1) Mutation.

N Engl J Med 2018 05;378(20):1945-1947

Memorial Sloan Kettering Cancer Center, New York, NY

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1511490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062005PMC
May 2018

Locally Aggressive Connective Tissue Tumors.

J Clin Oncol 2018 01 8;36(2):202-209. Epub 2017 Dec 8.

Mrinal M. Gounder and William D. Tap, Memorial Sloan Kettering Cancer Center and Weil Cornell Medical School, New York, NY; and David M. Thomas, Garvan Institute of Medical Research, Darlinghurst, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.8482DOI Listing
January 2018

Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

Ann Thorac Surg 2017 Dec 2;104(6):1837-1845. Epub 2017 Nov 2.

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2017.07.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696033PMC
December 2017

Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors.

Mol Cell Oncol 2018 7;5(1):e1384882. Epub 2017 Nov 7.

Louis V. Gerstner Graduate School of Biomedical Science and the Program in Molecular Biology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/23723556.2017.1384882DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791849PMC
November 2017

GeDDiS: insight into frontline therapy in soft tissue sarcoma.

Authors:
William D Tap

Lancet Oncol 2017 10 4;18(10):1297-1299. Epub 2017 Sep 4.

Memorial Sloan Kettering Cancer Institute, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30672-1DOI Listing
October 2017

ATRX is a regulator of therapy induced senescence in human cells.

Nat Commun 2017 08 30;8(1):386. Epub 2017 Aug 30.

The Louis V. Gerstner Graduate School of Biomedical Sciences, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-017-00540-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577318PMC
August 2017

Gemcitabine kills proliferating endothelial cells exclusively via acid sphingomyelinase activation.

Cell Signal 2017 06 24;34:86-91. Epub 2017 Feb 24.

Laboratory of Signal Transduction, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2017.02.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565230PMC
June 2017

Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma.

Cancer Res 2017 06 6;77(11):3113-3120. Epub 2017 Apr 6.

Radiology and Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-3310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457322PMC
June 2017

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.

J Clin Oncol 2016 09 25;34(26):3166-74. Epub 2016 Jul 25.

Mrinal M. Gounder, William D. Tap, Mark A. Dickson, Mary Louise Keohan, Sandra P. D'Angelo, Mercedes Condy, Lanier Tanner, Joseph P. Erinjeri, and Francis H. Jasmine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Alona Zer, Samer Salah, Abha A. Gupta, Herbert H. Loong, Stephanie Baker, Kjirsten Nyquist-Schultz, and Albiruni Ryan Abdul Razak, Princess Margaret Cancer Center, Toronto, Ontario, Canada; and Sharon Friedlander, Robert Carlson, Thaddeus J. Unger, Jean-Richard Saint-Martin, Tami Rashal, Joel Ellis, Michael Kauffman, and Sharon Shacham, Karyopharm Therapeutics, Newton, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.6346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321073PMC
September 2016

Current status of engineered T-cell therapy for synovial sarcoma.

Immunotherapy 2016 09;8(9):1073-80

Memorial Sloan Kettering Cancer Center, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2016-0026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618931PMC
September 2016

Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas.

PLoS One 2015 24;10(9):e0133610. Epub 2015 Sep 24.

Department of Pediatrics, Division of Hematology/Oncology, Gwynne Hazen Cherry Memorial Laboratories, University of California, Los Angeles, Los Angeles, California, United States of America; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, United States of America; California NanoSystems Institute, University of California, Los Angeles, Los Angeles, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0133610PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581723PMC
June 2016

Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.

Am J Surg Pathol 2016 May;40(5):645-55

*Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan ‡Department of Pathology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan Departments of †Pathology §Surgery ∥Medicine, Memorial Sloan Kettering Cancer Center ¶Department of Medicine, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000582DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833528PMC
May 2016

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.

N Engl J Med 2015 Jul;373(5):428-37

From Memorial Sloan Kettering Cancer Center (W.D.T., J.H.H.) and Weill Cornell Medical College (W.D.T.) - both in New York; University of California, Los Angeles, Medical Center, Los Angeles (Z.A.W., B.C., A.S.S.), Plexxikon, Berkeley (P.N.I., C.Z., J.Z., G.H., Y.Z., E.A.B., G.V., L.S., P.S., H.N., M.J.K., A.M., G.T., R.S., C.G., B.L.W., P.H., K.N., H.H.H., P.S.L., S.T.-S., G.B.), and Stanford University School of Medicine, Stanford (M.R.) - all in California; Evergreen Hematology and Oncology, Spokane, WA (S.P.A.); University of Pennsylvania School of Medicine, Philadelphia (A.P.S.); Rocky Mountain Cancer Centers, Denver (A.L.C.); Dana-Farber Cancer Institute (G.I.S., A.J.W.) and Massachusetts General Hospital (E.L.K.) - both in Boston; Vanderbilt University Medical Center, Nashville (V.L.K., I.P.); Virginia G. Piper Cancer Center at Scottsdale Healthcare-Translational Genomics Research Institute (TGen), Scottsdale, AZ (D.D.V.H., G.J.W., R.K.R.); and Spire Sciences, Boca Raton, FL (C.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1411366DOI Listing
July 2015

Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth.

Cancer Discov 2015 Mar 8;5(3):304-15. Epub 2015 Jan 8.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Medicine, Weill Cornell Medical College, New York, New York. Cell and Developmental Biology, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-0985DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355391PMC
March 2015

Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome.

Neoplasia 2015 Feb;17(2):183-9

Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2014.12.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351299PMC
February 2015

Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors.

Mol Cancer Res 2014 Dec 4;12(12):1740-54. Epub 2014 Aug 4.

Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California. Division of Hematology/Oncology, Department of Pediatrics, Gwynne Hazen Cherry Memorial Laboratories, University of California, Los Angeles, Los Angeles, California. Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California. California NanoSystems Institute, University of California, Los Angeles, Los Angeles, California.

View Article

Download full-text PDF

Source
http://mcr.aacrjournals.org/cgi/doi/10.1158/1541-7786.MCR-14
Publisher Site
http://dx.doi.org/10.1158/1541-7786.MCR-14-0159DOI Listing
December 2014

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.

Nat Genet 2014 Nov 21;46(11):1227-32. Epub 2014 Sep 21.

1] Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. [2] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. [3] Department of Medicine, Weill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249650PMC
November 2014

Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients.

BMC Cancer 2014 Nov 15;14:827. Epub 2014 Nov 15.

Department of Surgery, University of California - Los Angeles, Division of Surgical Oncology, 10833 Le Conte Ave, Room 54-140 CHS, 90095-1782 Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237782PMC
November 2014

Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs.

Clin Cancer Res 2014 Jun 9;20(12):3146-58. Epub 2014 Apr 9.

Authors' Affiliations: Jennifer Goodman Linn Laboratory of New Drug Development, Department of Medicine, Department of Molecular Pharmacology and Chemistry, Department of Surgery, Memorial Sloan Kettering Cancer Center; and Division of Hematology/Oncology, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/20/12/3146.ful
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-2576DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060793PMC
June 2014

That's the "GIST" of it: use of adjuvant imatinib after resection of a primary GI stromal tumor.

J Clin Oncol 2014 May 17;32(15):1543-6. Epub 2014 Mar 17.

Memorial Sloan-Kettering Cancer Center, New York, NY

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.5971DOI Listing
May 2014

Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine.

Int J Radiat Oncol Biol Phys 2014 Apr;88(5):1085-91

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2013.12.042DOI Listing
April 2014

Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.

Cancer 2012 Dec 30;118(23):5888-93. Epub 2012 May 30.

Department of Orthopedics, UCLA Orthopedic Hospital, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California 90095-1782, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27651DOI Listing
December 2012

Clinical trial end points for assessing efficacy of novel therapies for soft-tissue sarcomas.

Expert Rev Anticancer Ther 2012 Sep;12(9):1217-28

Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Santa Monica, CA 90404, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.12.100DOI Listing
September 2012

Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities.

Pediatr Res 2012 Aug;72(2):112-21

Molecular Biology Interdepartmental PhD Program, University of California, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/pr.2012.54DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283808PMC
August 2012

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas.

Sarcoma 2010 18;2010:143540. Epub 2010 Apr 18.

Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095-1782, USA.

View Article

Download full-text PDF

Source
http://downloads.hindawi.com/journals/sarcoma/2010/143540.pd
Web Search
http://www.hindawi.com/journals/sarcoma/2010/143540/
Publisher Site
http://dx.doi.org/10.1155/2010/143540DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855986PMC
July 2011

Evaluation of well-differentiated/de-differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization.

Genes Chromosomes Cancer 2011 Feb;50(2):95-112

Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20835DOI Listing
February 2011

Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram.

Cancer 2010 Aug;116(16):3883-91

Department of Surgery, Division of Surgical Oncology, University of California at Los Angeles, Los Angeles, California 90095-1782, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25271DOI Listing
August 2010

Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.

Neoplasia 2010 Aug;12(8):637-49

Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915408PMC
http://dx.doi.org/10.1593/neo.10414DOI Listing
August 2010

Utilization of positron emission tomography in the management of patients with sarcoma.

Curr Opin Oncol 2009 Jul;21(4):345-51

Departments of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California 90095, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-oncology/2009/07000/Utilizat
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e32832c95e2DOI Listing
July 2009

The multidisciplinary management of osteosarcoma.

Curr Treat Options Oncol 2009 Apr 24;10(1-2):82-93. Epub 2009 Feb 24.

Division of Pediatric Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-009-0087-3DOI Listing
April 2009

FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.

Clin Cancer Res 2009 Apr 7;15(8):2856-63. Epub 2009 Apr 7.

Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095-1782, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2537DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068269PMC
April 2009

Targeted therapies for soft-tissue sarcomas.

Expert Rev Anticancer Ther 2007 May;7(5):725-33

UCLA Sarcoma Program, Division of Hematology/Oncology, Los Angeles, CA 90095-7059, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.7.5.725
Publisher Site
http://dx.doi.org/10.1586/14737140.7.5.725DOI Listing
May 2007

Advances in chemotherapy for patients with extremity soft tissue sarcoma.

Orthop Clin North Am 2006 Jan;37(1):15-22

University of California, Los Angeles, UCLA Medical Center, 90095-1782, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ocl.2005.07.001DOI Listing
January 2006